Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 824-827

  Kian, Tham Chee ^a   Miriam, Tao ^a   Richard, Quek ^b   Peng, Yap Swee ^b   Li, Loong Er ^b   Ivy, Sng ^c   Hwan Cheong, Tan Leonard ^c   Hua, Li Hui ^b   Thye, Lim Soon ^a  

^a Department of Medical Oncology ^*  (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ASIAN; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; BURKITT LYMPHOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 42049093271     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701882948     Document Type: Conference Paper

References (14)

1. Magrath, I. T. (1990) The pathogenesis of Burkitt's lymphoma. Adv Cancer Res, 55, pp. 133-270.
2. Burkitt, D. P. (1983) The discovery of Burkitt's lymphoma. Cancer, 51, pp. 1777-1786.
3. Harris, N., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K. and Vardiman, J. (1999) World health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Arlie House, Virginia, November 1997. J Clini Oncol, 17, pp. 3835-3849.
4. Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. and Tubiana, M. (1971) Report of a committee on Hodgkin's disease staging classification. Cancer Res, 31, pp. 1860-1861.
5. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Eng J Med, 329, pp. 987-994.
6. Bernstein, J., Coleman, C., Strickler, J., Dorfman, R. and Rosenberg, S. (1986) Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol, 4, pp. 847-858.
7. Thomas, D., Cortes, J., O'Brien, S., Pierce, S., Faderl, S. and Albitar, M. (1999) HyperCVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol, 17, pp. 2461-2470.
8. Thomas, D., Faderl, S., Kantarjian, H., O'Brien, S., Bueso-Ramos, C., Cortes, J., Garcia-Manero, G., Giles, F. J., Verstovsek, S., Wierda, W. G., Pierce, S. A., Shan, J., Brandt, M., Hagemeister, F. B., Keating, M. J. and Cabanillas, F. (2006) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 106, pp. 1569-1580.
9. Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Müller-Weihrich, S. and Sauter, S. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol, 13, pp. 359-372.
10. Blum, K. A., Lozanski, G. and Byrd, J. C. (2004) Adult Burkitt leukemia and lymphoma. Blood, 104, pp. 3009-3020.
11. Ferry, J. A. (2006) Burkitt's lymphoma: Clinicopathologic features and differential diagnosis. Oncologist, 11, pp. 375-383.
12. Magrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N. and Gootenberg, J. (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regime. J Clin Oncol, 14, pp. 925-934.
13. Mead, G. M., Sydes, M. R., Walewski, J., Grigg, A., Hatton, C. S. and Norbert, P. (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: Results of United Kingdom Lymphoma Group LY06 study. Ann Oncol, 13, pp. 1264-1274.
14. Labrecque, L. G., Xue Shao-an, Griffin, B. E., Kazembe, P., Phillips, J., Lampert, I. and Wedderburn, N. (1999) Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: Correlation with patient response to therapy. Int J Cancer, 81, pp. 6-11.